Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir + Etravirine dual therapy to maintain viral suppression in older HIV-1 patients
2014-000828-24Phase 2Completed
- Sponsor
- Inserm-ANRS
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of raltegravir and etravirine in human immunodeficiency virus infection (HIV), sponsored by Inserm-ANRS. Primary endpoint: Virological success at week 48. Started Jun 2015; status: completed.
02
Drugs
raltegraviretravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2014-000828-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000828-24.